Injectable Drug Delivery Solutions

  1. A/L/P Assembly, Label And Packaging 11/7/2025

    Integrated device assembly, labeling, and packaging solutions streamline pharma delivery, ensuring compliance, scalability, and patient-centric design from clinical trials to commercial production.

  2. Non-Viral Gene Delivery (NVGD) Using Polymeric-Nano Particles

    Examine a NVGD platform that tackles the primary obstacle hindering gene editing therapies: efficient delivery. Utilizing engineered nanoparticles, the platform overcomes limitations associated with payload size.

  3. Sterile Drug Product 10/14/2025

    Accelerate sterile injectable development with expert support, advanced facilities, and tailored solutions for complex APIs — from formulation through commercialization across small molecules and biologics.

  4. Sterile Formulation And Fill/Finish For Early-Phase Clinical Trials Of Insoluble Drugs 1/28/2022

    Ascendia’s team of scientists have decades of combined experience in sterile supplies for clinical trials, making them expert at solving the most difficult formulation challenges. In short, we consistently make the insoluble soluble.

  5. Transforming Drug Delivery 3/1/2024

    Learn how our team of scientists, engineers, and human-centered designers, as well as our world-class facilities, empower us to confidently guide your product toward a successful market launch.

  6. Pre-Formulation And Material Sciences 3/3/2022

    Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.

  7. Pharmaceutical Vial Filling Equipment: VFM 4/28/2021

    VFM automatic filling and stoppering machines are designed for injectable solutions in vials.

  8. Robotic Multi-Format Filling & Closing System 1/2/2020

    AST’s ASEPTiCell® is a flexible fill/finish system that can efficiently process medium-sized clinical and commercial batches while meeting all cGMP requirements for cleanliness and sterility.

  9. Formulations For Poorly Soluble And Low Bioavailability Drugs 1/28/2022

    Ascendia specializes in the development of market suitable formulations for poorly water soluble drug substances. Based on the pre-formulation data package and the delivery requirements for the product, we recommend a comprehensive formulation development strategy. We understand that each formulation is unique and must address the specific challenges associated with poor solubility, inadequate bioavailability, and/or unacceptable physical/chemical stability. We also understand the urgency companies have for progressing their pipeline, and our approach maximizes the probability of success by exploring multiple formulation options in parallel if necessary.

  10. Pharmaceutical Development 4/24/2023

    Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.